FOLLOW OUR SCIENCE

OUR NEWS

NEWS

  • Media

The Times Magazine : Brenus Pharma Secures $25 Million to Propel Clinical Trials for Precision Cancer Vaccines

Read more

NEWS

  • Media

EU Startup – Lyon-based Brenus Pharma raises €22.2 million for precision cancer vaccines

Read more

NEWS

  • Media

BMF Business (FR) French Tech : Vaccins, futur de la lutte contre le cancer ?

Read more

NEWS

  • Media

Les Echos (FR) – Brenus Pharma réunit 22 millions pour lancer les essais cliniques de son vaccin anticancer

Read more

NEWS

  • Team

It’s a wrap San Diego! #BIO2024

Read more

NEWS

  • Events

Onco Startup Summit → Financements Non-dilutifs : “Comment naviguer à travers les possibilités et faire les bons choix”

Read more

NEWS

  • Events

Creative Destruction Lab – Graduates of 2023/2024

Read more

NEWS

  • Events

Join us at BIO International Convention #BIO2024

Read more

NEWS

  • Events

Join us at ASCO 2024

Read more

NEWS

  • Events

Brenus Pharma, French ambassador #Boosters

Read more

NEWS

  • Press Release

[📢Efficacy of the STC-1010, a new allogeneic cancer vaccine in different colorectal cancer models #AACR24]

Read more

NEWS

  • Press Release

[📢Brenus awarded French Biotech of the year 2024 🏆🎉]

Read more

NEWS

  • Press Release

[📢5M€ to obtain safety and efficacy clinical data in colorectal cancer 🎉]

Read more

NEWS

  • Press Release

[📢PSCC : Let’s collaborate at the heart of innovation in oncology 🚀]

Read more

NEWS

  • Press Release

[📢Stimulated Tumor Cells (STC) vaccine induces response in colorectal cancer #SITC23]

Read more

NEWS

  • Press Release

[📢Brenus annouces its international scientific committee]

Read more

NEWS

  • Press Release

[📢 BRENUS Pharma unveils groundbreaking preclinical results for STC-10101 , a promising new drug candidate targeting Colorectal Cancer & Solid Tumors. #AACR23]

Read more

NEWS

  • Press Release

[📢 French Blood Establishment (EFS) & Brenus Pharma partner for the GMP production of STC-1010, an innovative therapy against colorectal cancer]

Read more

NEWS

  • Press Release

[📢Pharma announces its Strategic Committee supporting & ensuring its value-creating strategic plan]

Read more

NEWS

  • Press Release

[📢Brenus Pharma and InSphero receive €1.5 million in grants from the European EUROSTARS fund for the development of a companion test for the next-generation cancer cell immunotherapy STC-1010]

Read more

NEWS

  • Poster

AACR 2024 Annual meeting

Read more

NEWS

  • Poster

SITC 2023 Annual meeting

Read more

NEWS

  • Poster

ASCO annual meeting 2023

Read more

NEWS

  • Poster

AACR Annual meeting 2023

Read more

NEWS

  • Poster

SITC annual meeting 2022

Read more

NEWS

  • Poster

AACR annual meeting 2022

Read more

NEWS

  • Poster

AACR 2021 Annual Conference

Read more

NEWS

  • Events

Onco Startup Summit → Financements Non-dilutifs : “Comment naviguer à travers les possibilités et faire les bons choix”

Read more

NEWS

  • Events

Creative Destruction Lab – Graduates of 2023/2024

Read more

NEWS

  • Events

Join us at BIO International Convention #BIO2024

Read more

NEWS

  • Events

Join us at ASCO 2024

Read more

NEWS

  • Events

Brenus Pharma, French ambassador #Boosters

Read more

NEWS

  • Events

Join us at MEET2WIN 2024

Read more

NEWS

  • Events

Join us at BIO Europe Spring

Read more

NEWS

  • Events

Hybridays 2024

Read more

NEWS

  • Events

Join us at PSCC Innovation Forum 2024

Read more

NEWS

  • Events

[#NEXTHealthcare] The NEXT Roadshow is only a week away! 🎉

Read more

NEWS

  • Team

It’s a wrap San Diego! #BIO2024

Read more

NEWS

  • Team

🎬 BEHIND THE SCENE – Lionel Chalus, Head of Technical Operations

Read more

NEWS

  • Team

📹 Brenus Pharma final pitch “Trophée Biotech” France Biotech

Read more

NEWS

  • Team

🎬 BEHIND THE SCENE – Corinne TORTORELLI, Sr Lead Medical Affairs

Read more

NEWS

  • Team

🔔 Project Update | Allogenix Consortium 🔔

Read more

NEWS

  • Team

🎬 BEHIND THE SCENE – Léa Perles : Strategic Operation Lead

Read more

NEWS

  • Team

Happy New Year 2024 !

Read more

NEWS

  • Team

Panel participation at 23rd Biotech in Europe forum

Read more

NEWS

  • Team

🎧Paul Bravetti, CEO Brenus Pharma – Taking the risk of launching a biotech company – Pharma Minds Podcast

Read more

NEWS

  • Media

The Times Magazine : Brenus Pharma Secures $25 Million to Propel Clinical Trials for Precision Cancer Vaccines

Read more

NEWS

  • Media

EU Startup – Lyon-based Brenus Pharma raises €22.2 million for precision cancer vaccines

Read more

NEWS

  • Media

BMF Business (FR) French Tech : Vaccins, futur de la lutte contre le cancer ?

Read more

NEWS

  • Media

Les Echos (FR) – Brenus Pharma réunit 22 millions pour lancer les essais cliniques de son vaccin anticancer

Read more

INCREASE IMMUNOGENICITY

Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system  with visible and multi-specific targets

More about Haptenization & STC immunogenicity
Back to the page

REPRESENT HETEROGENEITY OF THE TARGETED INDICATION

Selection criteria of starting material (Allogeneic tumor cell lines)

  • Representative oncogenic drivers (TP53,BRAF,KRAS,…)
  • Cold & hot tumor cell lines
  • Resistances capacities (metabolic ; chemical & physical)
Back to the page

Increase antigenicity

Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system  with a broad & higher quality range of tumor antigens

More about STC Antigenicity
Back to the page